Acute leukemia is associated with a wide spectrum of recurrent, non-random chromosomal translocations. Molecular analysis of the genes involved in these translocations has led to a better understanding of both the causes of chromosomal rearrangements as well as the mechanisms of leukemic transformation. Recently, a number of laboratories have cloned translocations involving the NUP98 gene on chromosome 11p15.5, from patients with acute myelogenous leukemia (AML), myelodysplastic syndrome (MDS), chronic myelogenous leukemia (CML), and T cell acute lymphoblastic leukemia (T-ALL). To date, at least eight different chromosomal rearrangements involving NUP98 have been identified. The resultant chimeric transcripts encode fusion proteins that juxtapose the N-terminal GLFG repeats of NUP98 to the C-terminus of the partner gene. Of note, several of these translocations have been found in patients with therapy-related acute myelogenous leukemia (t-AML) or myelodysplastic syndrome (t-MDS), suggesting that genotoxic chemotherapeutic agents may play an important role in generating chromosomal rearrangements involving NUP98. Leukemia (2001) 15, 1689-1695.
Introduction
Similar to other malignancies, leukemia is a heterogeneous disease. This observation is presumably a direct manifestation of the vast array of genomic changes that occur in leukemic cells. However, certain types of leukemia are often associated with very specific, recurrent chromosomal abnormalities, most commonly chromosomal inversions or translocations. [1] [2] [3] [4] Correlation of recurrent chromosomal abnormalities with clinical features allows the establishment of new disease classifications and therapeutic approaches. Importantly, these chromosomal abnormalities have begun to serve as biomarkers useful in identifying distinct clinical subgroups with predictable clinical features and therapeutic responses. 5, 6 The cloning of chromosomal breakpoints and genes involved in chromosomal rearrangements has also provided considerable insight into the mechanisms of chromosomal rearrangement and leukemic transformation.
The first case reports of a t(7;11)(p15;p15.5) associated with acute myelogenous leukemia (AML) or chronic myelogenous leukemia (CML) were published in 1982. 7 Subsequently, two laboratories identified nucleoporin 98 kD (NUP98) as one of the genes involved in the t(7;11)(p15;p15.5). 8, 9 This observation has led to the identification and cloning of at least eight different fusion transcripts encoding NUP98 fusion proteins. [10] [11] [12] [13] [14] [15] [16] These chromosomal abnormalities are present in the malignant cells of patients with both myeloid and lymphoid malignancies, including AML, CML, myelodysplastic syndrome (MDS), and T cell acute lymphoblastic leukemia (T-ALL). This review will summarize the clinical and biological features of this emerging class of chromosomal rearrangements.
Structure and function of NUP98
The NUP98 protein is a component of the nuclear pore complex (NPC), which regulates nucleocytoplasmic transport of protein and RNA ( Figure 1a ). [17] [18] [19] [20] [21] [22] The yeast NPC consists of approximately 30 nucleoporins; 23 the mammalian NPC has been estimated to contain 50-100 different proteins. 20, 22, 24 NUP98 resides asymmetrically at the nucleoplasmic side of the NPC and colocalizes with TPR (translocated promoter region) to intranuclear sites, extending to and perhaps within the nucleolus. 17, 20, 25 NUP98 belongs to a subgroup of nucleoporins, which contains FXFG or FG repeats (Figure 1b) . Unlike the other members of this subgroup, NUP98 also contains GLFG repeats. The 37 FG repeats are located in the N-terminus and comprise the first and third functional domains of
Figure 1
Representation of the nuclear pore complex (NPC) and the functional domains of the nucleoporin 98kD protein (NUP98). (a) The nuclear localization of NUP98, subsequent to autoproteolysis in the nucleoplasm, is indicated by this schematic of the NPC. TAP and RAE1 have been localized to the cytoplasm and nucleoplasm as well as on both sides of the NPC. NUP98 colocalizes with TPR at the nuclear basket of the NPC and also within the nucleoplasm. CC, central core; CF, cytoplasmic filaments; CR, cytoplasmic ring; NR, nuclear ring; NB, nuclear basket; NE, nuclear envelope; NO, nucleolus. (b) The Phe-Gly (FG) repeats of NUP98 are indicated, as are the RAE1 (GLEBS) and RNA binding domains (bd). An asterisk marks residue 863 where autoproteolysis truncates the NUP98 protein.
the NUP98 protein. These FG repeats have been shown to be docking sites for transport receptors such as karyopherin ␤1, which interacts with karyopherin ␣ to form a heterodimer transport complex. Karyopherin ␣ recognizes the nuclear localization signals (NLS) and nuclear export signals (NES) of substrates that are being transported, but requires karyopherin ␤1 to dock on to nucleoporins. 17, [26] [27] [28] Once docked, the small GTPase Ran and p10 (NTF2) facilitate entry into or out of the nucleus.
Although karyopherin ␤1 binds the FG repeats of NUP98, whether NUP98 actually plays a direct role in protein transport is unclear since depletion of NUP98 does not seem to disrupt protein transport in reconstituted nuclei.
29 NUP98-specific antibodies inhibit the transport of snRNA, 5S RNA, large rRNA, and mRNA without perturbing other functions, 19 but NUP98-deficient embryonic stem (ES) cells remain viable, suggesting that NUP98 is not required for mRNA transport. [17] [18] [19] [20] [21] [22] Other studies suggest that the role of NUP98 in RNA transport may be mediated by TAP (TIP associated protein), a novel cellular factor first identified for its interaction with TIP (tyrosine kinase-interacting protein) (Figure 1a) . [30] [31] [32] TAP is required for export of cellular mRNA substrates. The glutamine-rich C-terminal domain of TAP interacts with the FG repeats of NUP98. Thus, in conjunction with other nuclear proteins, TAP appears to mediate mRNA export through its interaction with NUP98.
The second and fourth functional domains of NUP98 contain a GLEBS-like motif and a RNP binding motif, respectively, surrounded by charged residues (Figure 1b) . In a recent report, the NUP98 C-terminus has also been shown to function as a nuclear localization signal (NLS). 25 GLEBS motifs serve as binding sites for RAE1-a molecule purported to be a mRNAspecific carrier containing the nuclear export signal (NES) (Figure 1a) . 33 RAE1 and TAP both bind to NUP98 and, at the same time, can bind to mRNA-associated proteins. Since mRNA traverses the NPC as part of a RNP complex, it seems likely that RAE1 and TAP act as nuclear transport receptors for mRNA, much like karyopherins for proteins. Although the function of the putative RNP binding domain is unknown, given the data on NUP98's role in mRNA transport, this domain may also participate in mRNA transport.
The NUP98 gene is located on chromosome 11p15.5 near an imprinted region that includes IPL, IGF2 and H19; 34 however, NUP98 is not imprinted in the mouse (DHL and PDA, unpublished data). Two major NUP98 transcripts of 4.0 and 7.0 kb can be detected. The 4.0 kb transcript consists of 20 exons 35 ( Figure 2a ) and encodes a 920 amino acid (aa) protein. 20 Several minor NUP98 transcripts are produced through alternative splicing (Figure 2b ). One alternatively spliced form deletes 570 bp from the full-length transcript and results in the loss of residues 254 to 444. 36 Two other rare transcripts result from either a 51 bp extension of the 3Ј end of exon 10 37 or from splicing around exon 12.
38 Interestingly, these alternate splice forms can be detected in both human and mouse NUP98 transcripts (DHL and PDA, unpublished data). Recently, it was reported that another rare transcript is produced by splicing around exons 3 and 4. 22 In all of these alternatively spliced transcripts, the reading frame is preserved, encoding a truncated NUP98 protein.
The 7.0 kb transcript is unique in that it encodes a NUP98-NUP96 precursor protein (Figure 2b) . 20 This 7.0 kb transcript is created by splicing NUP98 exon 20 sequences (corresponding to residue 914) to downstream exons encoding the NUP96 protein. This alternatively spliced transcript encodes a precursor protein of 1712 aa, with a molecular mass of 186 kDa. The precursor is then proteolytically cleaved to produce NUP98 and NUP96 proteins. In order for NUP98 to be properly targeted to the nuclear basket, both the NUP98-NUP96 precursor and the immature NUP98 protein must be cleaved to produce an 863 aa NUP98 protein. 20 Upon cleavage of the immature NUP98 protein, a 6 kDa oligopeptide containing an NLS is produced from the C-terminus; this 6 kDa product remains associated with NUP98. 25 Posttranslational modification occurs in the nucleoplasm through autoproteolysis, not requiring additional proteases. 39 This remarkable biogenesis pathway is evolutionarily conserved between Homo sapiens and Saccharomyces cerevisiae.
NUP98 partner genes I: the HOX family
The nucleoporins were first studied in Saccharomyces cerevisiae and Xenopus laevis. 17, 40, 41 These studies led to the cloning and characterization of the rat NUP98. 18 Subsequently, the human NUP98 gene was identified at the site of a t(7;11)(p15;p15.5) chromosomal translocation. 8, 9 The partner gene in this translocation was the homeobox gene HOXA9. Since then, two other chromosomal translocations have been shown to result in NUP98-homeobox fusions, the t(2;11)(q31;p15.5) 11 and t(1;11)(q23;p15.5), 12 involving, HOXD13 and PMX1, respectively ( Table 1) .
The HOX or homeobox genes are a superfamily of tran- 42, 43 Members of the HOX family share a 60 aa sequence, which constitutes the DNA binding homeodomain of these proteins (Figure 3a) . Mammalian HOX genes are organized into four clusters (A, B, C and D) located on human chromosomes 7, 17, 12, and 2, respectively. 44, 45 The 39 genes in these four clusters are referred to as class-I homeobox genes. There are also numerous class-II or 'orphan' homeobox genes, which contain a divergent homeodomain, dispersed throughout the genome.
Notably, three of the four clusters (clusters A, B and C) have been shown to regulate normal and leukemic hematopo- Leukemia iesis. 46 Studies with leukemia cell lines suggested that there may be some lineage specificity for these three clusters. For example, clusters B and C are expressed mainly in erythroid cell lines whereas cluster A is predominantly expressed in myeloid cell lines. [47] [48] [49] [50] Expression of virtually all the HOX genes of the A, B and C clusters is detected in normal primitive hematopoietic cells. 46 Expression of HOX cluster genes tends to decline in a pattern that follows their chromosomal position; genes in the 3Ј region are downregulated earlier than genes in the 5Ј region of each cluster. As hematopoietic stem cells become increasingly committed to a specific lineage, there is a loss of HOX gene expression. 51 Some 'orphan' homeobox genes are expressed during normal hematopoietic development as well. However, the entire D cluster may be non-essential for normal blood cell development. Expression of HOXD cluster genes has not been detected in normal hematopoietic cells, 46 and neither Hoxd-13 nor Hoxd-11-Hoxd-13 knock-out mice show defects in hematopoiesis. 52 A regulatory role for HOX genes in normal and malignant hematopoiesis can be inferred from experiments in which expression of specific genes have been blocked or amplified in cell lines or animal models. 46 Overexpression of HOXA10 in bone marrow cells results in AML when these cells are transplanted into sub-lethally irradiated mice. 53 Insertional activation of Hoxa-7 or Hoxa-9, in collaboration with activation of Meis1 (a Pbx-related 'orphan' homebox gene) also leads to AML in mice, 54 and mRNA expression profile experiments have demonstrated that HOXA9 is frequently expressed in AML cells. 55 Intriguingly, the t(1;19)(q23;p13) in human ALL creates a chimeric E2A-PBX1 protein; this protein has been shown to be oncogenic in a transgenic mouse model. 56 Prior to the discovery of the NUP98 gene fusions, HOX11 57 and the aforementioned PBX1 58 were the only homeobox genes implicated in human leukemia. The first class-I HOX genes to be linked to human leukemias are HOXA9 8, 9 and HOXD13, 11 as partners in the NUP98 gene fusions. The NUP98 translocation involving the HOXA9 gene, t(7;11)(p15;p15.5), is associated with AML, MDS, and CML. Although it has been suggested that the t(7;11) is most commonly found in older Asian men, it remains unclear whether the racial or geographical predisposition is coincidental. 38, [59] [60] [61] [62] [63] [64] HOXA9 consists of three exons: 1A, 1B and 2. The translocation breakpoint occurs between exons 1A and 1B, effectively separating the homeodomain in exon 2 from the regulatory elements in exon 1A (Figure 3a) . The NUP98 breakpoint in these translocations lies in either intron 11 or 12 ( Figure 2a) .
The t(2;11)(q31;p15.5) has been found in patients with AML and t-MDS/AML, and fuses NUP98 to HOXD13. 11, 65 Similar to HOXA9, the second exon of HOXD13 contains the highly conserved homeodomain, which is separated from its regulatory elements in the gene fusion since the breakpoint lies between the two exons (Figure 3a) . The breakpoint in NUP98 lies in intron 12, the most common breakpoint region ( Figure  2a) . A variant of this translocation has a breakpoint upstream of the HOXD13 gene, adjacent to a putative gene called FN1. 37 In this case, both NUP98-FN1 and NUP98-HOXD13 fusion transcripts can be detected in the same patient.
A third HOX gene implicated in NUP98 translocations is PMX1. The t(1;11)(q23;p15.5) is associated with t-AML and produces a NUP98-PMX1 fusion gene. 12, 66 PMX1 is a class-ll homeobox gene that has a genomic structure similar to HOXA9 in that the homeodomain of PMX1 is located in exon 2. The breakpoint in PMX1 lies between exons 1A and 1B (Figure 3a) . Alternative splicing fuses NUP98 to both exons 1B and 2 of PMX1, producing two chimeric transcripts. Although the fusion of NUP98 to PMX1 exon 2 encodes a NUP98-homeodomain similar to NUP98-HOXA9 and NUP98-HOXD13, PMX1 exon 1B is non-coding and would result in the production of a truncated NUP98-PMX1 fusion protein.
Two other translocations found in t-MDS/AML patients, t(11p15.5;17q21) and t(11p15.5;12q13), 62 may also generate NUP98-HOX fusions. The 17q21 and 12q13 breakpoints in these two translocations map to the HOXB and HOXC clusters, respectively, raising the possibility that these translocations produce NUP98-HOXB and NUP98-HOXC fusions. However, proof that these rearrangements involve HOX genes awaits the molecular characterization of these translocations.
NUP98 partner genes II: the variants
In addition to the HOX genes described above, five other NUP98 fusion partners have been identified at the molecular level: DDX10, 10 TOP1, 14 
LEDGF,

15
NSD1, 16 and
RAP1GDS1
13 (Table 1) . Presently, there does not appear to be an obvious theme among these genes. The inv(11)(p15.5q22) is associated with AML and MDS, and generates two different in-frame fusion transcripts, with NUP98 exon 12 fused to DDX10 exon 6 or NUP98 exon 14 fused to DDX10 exon 7. 10, 67, 68 The DDX10 gene encodes a DEAD-box protein with a putative RNA helicase motif (Figure 3b ). DEAD box RNA helicases are implicated in a number of RNA metabolic pathways including splicing, translation, and ribosome assembly. In contrast to the HOX genes, DDX10 is ubiquitously expressed, but the reciprocal DDX10-NUP98 gene fusion is only detected sporadically.
Topoisomerase I (TOP1) is the NUP98 fusion partner in the t(11;20)(p15.5;q11). 14, 35 This translocation is also associated with MDS and AML. TOP1 is functionally organized into four domains (Figure 3b ) and normally carries out a cycle of transesterification reactions, during which it creates transient single-stranded DNA nicks, resulting in topological transformations of DNA. The TOP1 breakpoint leads to a separation of the TOP1 NLS and catalytic domains, and results in a fusion between the amino terminal portion of NUP98 and the TOP1 catalytic domain. Although a reciprocal fusion transcript is predicted, none have been isolated.
The t(9;11)(p22;p15.5), is associated with AML and leads to production of a NUP98-LEDGF fusion. 15 The LEDGF gene encodes the transcriptional coactivators p52 and p75 (also known as lens epithelium-derived growth factor) (Figure 3b) . The p52 and p75 isoforms are produced as a result of alternative splicing and differ only in their C-termini. 69 The N-terminus of p52 and p75 contains a HATH domain, followed by a linker region, and then an HMG-1 like C-terminal domain with highly charged residues. p52 is a potent activator of transcription and serves to bridge sequence-specific transcription activation proteins. 70 The LEDGF breakpoint is in the linker region, which would produce a fusion that contains the charged residues of LEDGF at the C-terminus. The 3Ј end of both the p52 and the p75 transcript is fused to exon 9 of NUP98 (Figure 2a) . Again, a reciprocal fusion transcript is presumed to exist, but has not been detected.
The t(5;11)(q35;p15.5), recently identified in several cases of childhood AML, fuses NUP98 exon 12 to the NSD1 gene. 16 In the mouse, nsd1 has been shown to exhibit the properties of both corepressors and coactivators of transcription, but the function of its human counterpart is unknown. Human NSD1 is expressed in hematological tissues, as shown by Northern analysis. 16 The chromosomal translocation breakpoint has not yet been isolated and further characterization of this novel human gene in the translocation is anticipated.
The t(4;11)(q21;p15) has the distinction of being the only NUP98 gene rearrangement associated with T-ALL (Table  1) . 13, 71, 72 The RAP1GDS1 gene on chromosome 4q21 codes for a ubiquitously expressed guanine nucleotide exchange factor called smgGDS (Figure 3b) . SmgGDS mediates conversion of inactive GDP-bound GTPases to the active GTP-bound form. However, it has been speculated that smgGDS might also play a role in nucleocytoplasmic transport, as smgGDS is composed of multiple armadillo repeats that are thought to mediate protein-protein interactions. NUP98 is fused to nucleotide 5 of the RAP1GDS1 ORF, preserving the entire protein except for the first methionine. One of the NUP98 breakpoints in these translocations lies in intron 12, whereas the other lies in intron 10 ( Figure 2a) . Regardless of which NUP98 exon (10 or 12) is fused to RAP1GDS1, the reading frame of the fusion transcript is preserved. As with the NUP98-DDX10 translocations, a reciprocal RAP1GDS1-NUP98 fusion transcript has been detected.
In all of the NUP98 translocations described thus far, a chimeric transcript consisting of the 5Ј portion of NUP98 fused in-frame to the 3Ј portion of the partner genes is generated. Despite the fact that the NUP98 breakpoints in these translocations are located between introns 9 to 14 (Figure 2a) , the FG repeats in the N-terminus are always retained ( Figure  3a) . Interestingly, FG repeats are also retained in translocations involving NUP214. 73, 74 In the t(6;9)(p23;q34), the FG repeats in the C-terminus of NUP214 are fused to the N-terminus of DEK. Similarly, in the interstitial deletion of 9q34, the N-terminus of SET is fused to the FG repeats of NUP214.
Possible mechanisms of translocation
Although initial studies indicated an association between NUP98 fusions and de novo AML, recent reports demonstrate that several of the reported NUP98 chromosomal rearrangements could be identified in patients with therapy-related AML or MDS (t-AML, t-MDS) ( Table 1) . [10] [11] [12] 14, 35, 62, 75 Additionally, 7% of all pediatric t-MDS/AML cases were associated with 11p15.5 translocations in one series. 75 The association of NUP98 gene rearrangements with t-AML/MDS suggests that the NUP98 locus may be susceptible to gross chromosomal rearrangements induced by genotoxic agents.
Thus far, there are only two reports in which the genomic translocation breakpoints have been characterized. In two cases of t-MDS and a t(11;20)(p15.5;q11), the genomic breakpoints showed 4 bp microduplications which the authors speculated might have been generated by a 4 bp staggered double-strand DNA break followed by inter-chromosomal strand exchange. 35 This observation is intriguing, given that topo II normally generates 4 bp staggered breaks and the patients had received topo II inhibitors. Moreover, a very similar translocation has been produced in vitro by treating cells with topo II inhibitors. 76, 77 The breakpoint junctions in a case of AML with a t(2;11)(q31;p15.5) were within intron 12 of NUP98 and upstream of both HOXD13 exon 1 and the putative FN1 gene on chromosome 2q31. 37 Sequence comparisons demonstrated that the translocation was not balanced at the molecular level and that 49 bp from chromosome 11 and 110 bp from chromosome 2 were duplicated and present on both the der (2) and der(11) chromosomes. Interestingly, the breakpoint in intron 12 of NUP98 lies within a LINE repetitive sequence. Similar to the t(11;20) described above, a potential mechanism for this translocation is again a staggered double-strand DNA break, followed by chromosomal interchange and repair.
Potential mechanisms of leukemic transformation
The association of chromosomal rearrangements that produce NUP98 fusion proteins with acute leukemia suggests that expression of NUP98 fusion proteins may be a causal event for leukemic transformation. Of note, a chimeric transcript that encodes the NUP98 N-terminal FG repeats fused to the C-terminus of the partner protein, is expressed in all NUP98 fusions reported, suggesting that the NUP98 N-terminus may be important for leukemogenicity. These FG repeats have been shown to activate transcription and interact with both CREB binding protein and p300. 12, 36 Expression of a NUP98-HOXA9 fusion protein induces transformation of NIH 3T3 fibroblasts in vitro. 36 Recently, two groups have reported that NUP98 fusion proteins are leukemogenic in murine bone marrow transplantation experiments. Ectopic expression of a NUP98-HOXA9 fusion in mouse bone marrow cells was shown to predispose mice to AML; this effect was accentuated by co-expression of Meis 1. 78 When expressed in differentiating murine embryonic stem cells, NUP98-HOXD13 fusion protein leads to an increase in myeloproliferation and decrease in erythropoiesis. 79 Furthermore, NUP98-HOXD13 induces myeloproliferation and, again in collaboration with Meis1, acute myeloid leukemia in murine bone marrow transplantation experiments. 80 Reports that NUP98 fusion proteins function as robust transcription factors imply that these fusion proteins localize to the nucleus. The NUP98-HOXA9, 36 NUP98-PMX1, 12 NUP98-RAP1GDS1, 72 and DEK-NUP214 81 fusion proteins do show nuclear localization, although NUP98-RAP1GDS1 can also be found in the cytoplasm. If NUP98 fusion proteins serve as transcription factors, then what are the downstream targets? Presumably, the fusion partners provide binding specificity and therefore can determine these downstream target genes. In the case of the HOX partners, such a mechanism is plausible since HOX genes play a role in hematopoietic development. It is more difficult to propose this mechanism for DDX10, LEDGF, NSD1, and RAP1GDS1 since these proteins are not known to have direct DNA binding capabilities nor are they implicated in blood cell development.
Alternatively, the FG domain of NUP98 may be the critical component, with the partners providing a non-specific function. There is precedence for such a mechanism. For instance, in MLL gene fusions, it has been suggested that the importance of partner genes lies principally in their capacity to facilitate oligomerization of the MLL fusion proteins. 82 Reviewing the function of the NUP98 partner genes described, it is tempting to invoke such a mechanism since most of the NUP98 partner genes encode products capable of protein-protein interactions. It is possible that NUP98 may indirectly control gene expression by a dominant-negative mechanism or by altering nucleocytoplasmic transport of mRNA and/or protein.
The studies of NUP98 gene fusions and leukemia reported thus far form only a framework from which to proceed. At least eight different genes are involved in NUP98 fusions and there seems to be a predilection for homeobox genes. A fusion transcript encoding the NUP98 FG repeats is consistently Leukemia expressed suggesting that the FG repeats possess an important function for leukemic transformation. Although it has been suggested that NUP98 translocations may be over-represented in the Asian population, additional surveys will be needed to determine the incidence and prevalence of these translocations, and to clarify the issue of racial predisposition. Additionally, the mechanisms leading to chromosomal rearrangement and leukemic transformation are proposed only tentatively and many important questions remain. For instance, do different mechanisms exist for different fusion proteins, or is there a unifying theme for all NUP98 fusion proteins? Finally, the clinical course of patients with NUP98 rearrangements seems quite aggressive and the outcome of treatment is disappointing. It is our hope that a better understanding of the disease process will help identify new treatment strategies to contend with this poor clinical outcome.
